Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn why index funds are a practical choice for long-term investing, emphasizing diversification, low fees, and a hands-off approach for steady growth.
28,023 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Fluence Energy’s stock surged after-hours on news of two hyperscaler storage deals, even as Q2 revenue disappointed. ...
President Trump nominates Cameron Hamilton to run FEMA, marking a surprising return to a central agency as disaster r...
Broadcom faced a sharp earnings-driven selloff, tumbling about 14% in a single day. This article spotlights an under-...
Kevin Warsh chairs his first FOMC meeting as crypto markets brace for policy clarity. Bitcoin steadies near 66,000 wh...
Ethereum bulls face a critical test as ETH approaches a long-standing resistance near the $2,000 mark. This ethereum ...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
Many retirees dream of a simpler life and fatter savings by moving to a smaller home. But does downsizing retirement ...
People often see citizenship as identity, but for many it’s a smart financial move. This article breaks down how prac...
Rising equity in rental properties creates powerful choices. This guide walks you through when to keep, when to sell,...
Short sellers now hold about 31% of SpaceX’s tradable float, a level that could ignite a volatile squeeze unless the ...